Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACH: Hydroxyurea for Children With Sickle Cell Anemia
NCT01966731Phase 2Active, not recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jun 2014
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of hydroxyurea in sickle cell anemia (SCA), sponsored by Cincinnati Children's Hospital Medical Center. Started Jun 2014; status: active, not recruiting.
02
Drugs
hydroxyurea
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT01966731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01966731.